Introduction

Medical devices are rapidly evolving into connected, software-driven ecosystems that support remote monitoring, data analytics and real-time clinical decision-making. While this transformation improves healthcare outcomes, it also expands the cyber threat landscape for manufacturers and healthcare providers.

Manufacturers in Switzerland that plan to export medical devices to Europe must comply with the European Union Medical Device Regulation (EU MDR). Cybersecurity validation through Vulnerability Assessment and Penetration Testing (VAPT) has become a critical requirement to demonstrate device safety, performance and resilience.

Cyberintelsys supports medical device manufacturers with EU MDR-aligned VAPT services that help identify vulnerabilities, validate security posture and provide compliance-ready documentation.

EU MDR Cybersecurity Expectations for Medical Devices

The EU MDR is enforced by the European Union and significantly strengthens cybersecurity requirements for medical devices entering the EU market.

Under EU MDR, cybersecurity is treated as a core component of product safety and lifecycle risk management.

Manufacturers must demonstrate:

• Secure design and development practices
• Evidence-based cybersecurity validation
• Continuous risk management
• Secure update and patching capabilities
• Post-market vulnerability monitoring
• Protection of patient data and device integrity

Cybersecurity testing and VAPT play a central role in proving compliance to notified bodies during CE marking.

Why VAPT is Critical for Medical Devices

Healthcare cyberattacks continue to rise globally and connected medical devices are increasingly targeted due to their critical role in patient care.

1. Protecting Patient Safety

Compromised medical devices can disrupt treatment delivery, alter therapy parameters, or interfere with clinical workflows. Identifying vulnerabilities early helps prevent real-world incidents.

2. Enabling EU Market Entry

EU MDR requires evidence of cybersecurity testing within technical documentation. VAPT reports provide the proof needed for certification.

3. Preventing Costly Recalls and Incidents

Security weaknesses discovered post-launch can result in recalls, regulatory action and reputational damage.

4. Strengthening Trust with Healthcare Providers

Hospitals and healthcare organizations increasingly demand proof of cybersecurity testing before adopting new devices.

Our Methodology for EU MDR VAPT

Cyberintelsys follows a structured and risk-driven testing approach aligned with EU MDR expectations and international best practices.

1. Scope Definition and Asset Identification

A comprehensive review defines the device ecosystem and testing boundaries.

Scope includes:

• Embedded systems and firmware
• Mobile and web applications
• Cloud platforms and APIs
• Network interfaces and wireless communications
• Backend infrastructure and databases

2. Threat Modeling and Attack Surface Analysis

Threat modeling identifies potential attack vectors and prioritizes risk areas.

Activities include:

• Identifying threat actors and misuse scenarios
• Mapping data flows and trust boundaries
• Evaluating exposed interfaces and entry points
• Risk scoring based on likelihood and impact

3. Vulnerability Assessment

Automated and manual assessments identify weaknesses across the device ecosystem.

Testing includes:

• Firmware and software vulnerability scanning
• Authentication and access control analysis
• Configuration and patch management review
• Cryptography and encryption validation

4. Penetration Testing

Real-world attack simulations validate device resilience against exploitation.

Testing scenarios include:

• Network intrusion attempts
• Firmware reverse engineering
• Wireless communication attacks
• Privilege escalation
• Cloud and API exploitation
• Data exfiltration simulations

5. Risk Analysis and Remediation Guidance

All findings are prioritized and mapped to risk severity.

Deliverables include:

• Risk rating and impact analysis
• Technical remediation recommendations
• Secure design improvement guidance
• Compliance-ready reporting

6. Compliance Documentation Support

Comprehensive reports support EU MDR technical files and CE certification processes.

Cyberintelsys VAPT Services for Medical Devices

Cyberintelsys delivers specialized VAPT services tailored to EU MDR compliance.

1. Medical Device Vulnerability Assessment

Systematic identification of security weaknesses across device components.

Coverage includes:

• Embedded operating systems and firmware
• Companion mobile and web applications
• Backend infrastructure and databases
• Communication protocols and APIs
• Cloud environments

2. Medical Device Penetration Testing

Simulated cyberattacks validate device security posture.

Testing covers:

• External and internal attack scenarios
• Firmware and hardware exploitation
• Wireless protocol testing (Bluetooth, Wi-Fi)
• Cloud and API penetration testing

3. Secure Architecture Review

Evaluation of device security architecture to identify design gaps.

Focus areas:

• Authentication and authorization mechanisms
• Secure firmware updates and secure boot
• Encryption and key management
• Network segmentation and isolation

4. Wireless and IoT Security Testing

Connected devices often rely on wireless communication.

Testing includes:

• Wireless protocol analysis
• Signal interception and replay testing
• Device pairing security validation
• Communication channel encryption testing

5. Cloud and Backend Security Testing

Assessment of platforms supporting remote monitoring and analytics.

Key activities:

• API security testing
• Cloud configuration assessment
• Identity and access management review
• Data storage and transmission security

6. Post-Market Security Support

EU MDR requires ongoing monitoring and vulnerability management.

Support includes:

• Continuous vulnerability scanning
• Security patch guidance
• Incident response planning
• Periodic reassessment

Why Choose Cyberintelsys

Healthcare and MedTech organizations rely on Cyberintelsys for trusted and compliance-focused security testing.

Cyberintelsys is a CREST-accredited cybersecurity company for Vulnerability Assessment (VA) and Penetration Testing (PT), delivering industry-recognized security testing services for organizations across multiple sectors.

1. Specialized Medical Device Security Expertise

Extensive experience in testing connected healthcare technologies and embedded systems.

2. EU MDR-Aligned Testing Approach

Security testing and reporting aligned with EU MDR expectations and certification requirements.

3. Risk-Based Testing Strategy

Assessments prioritize patient safety, regulatory compliance and real-world threat scenarios.

4. End-to-End Lifecycle Support

Coverage spans from early design assessment to post-market surveillance.

5. Global Market Enablement

Support helps manufacturers in Switzerland confidently enter the European medical device market.

Contact Us

EU MDR compliance requires rigorous cybersecurity validation and documented VAPT testing. Cyberintelsys helps medical device manufacturers in Switzerland strengthen security, meet regulatory expectations and prepare for successful CE certification.

Contact us today to strengthen device cybersecurity, reduce compliance risks and accelerate entry into the European healthcare market.